Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from HTGM

Short Volatility Alert: HTG Molecular Diagnostics, Inc.

On Tuesday, shares of HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) experienced volatile short activity. After the activity, the stock price went up +52.17% to $0.84. The overall sentiment for HTGM has been Bearish.

Benzinga · Jun 29, 2022

Recap: HTG Molecular Diagnostics Q1 Earnings

Recap: HTG Molecular Diagnostics Q1 Earnings

HTG Molecular Diagnostics (NASDAQ:HTGM) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · May 12, 2022

Earnings Outlook For HTG Molecular Diagnostics

Earnings Outlook For HTG Molecular Diagnostics

HTG Molecular Diagnostics (NASDAQ:HTGM) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that HTG Molecular Diagnostics will report an earnings per share (EPS) of $-0.71.

Benzinga · May 11, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Read Why HTG Molecular Shares Are Surging Today

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) says it has improved the sample preparation protocol for its miRNA Whole Transcriptome Assay (miRNA WTA) to be harmonized with the HTG Transcriptome Panel (HTP). The harmonized protocol enables customers to process a single sample with HTG's nearly 20,000 gene mRNA and 2,000+ miRNA transcriptome panels using a…

Benzinga · Apr 7, 2022

23 Stocks Moving in Thursday's Pre-Market Session

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) rose 46.7% to $1.88 in pre-market trading after the company announced it has harmonized its miRNA Whole Transcriptome Assay with the HTG Transcriptome Panel.

Benzinga · Apr 7, 2022

Looking Into HTG Molecular Diagnostics's Return On Capital Employed

HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $2.88 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.6%, resulting in a loss of $5.19 million.

Benzinga · Mar 30, 2022

Earnings Preview: HTG Molecular Diagnostics

HTG Molecular Diagnostics (NASDAQ:HTGM) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that HTG Molecular Diagnostics will report an earnings per share (EPS) of $-0.59.

Benzinga · Mar 28, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

1

Coverage From

Benzinga

Organisations

HTG Molecular Diagnostics

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play